In The Know

CiiTA Case Study: Sometimes it’s the State

A 340B transaction involves more than a manufacturer selling pharmaceuticals and a covered entity buying them. Because the transaction involves many parties, even when both the manufacturer and covered entity are processing transactions correctly on their respective ends, compliance can still hit a snag.

Read More

Jason Hardaway is Coming to Denver This Week for The AMCP Annual Meeting

CiiTA’s Managing Director Jason Hardaway will be presenting at The AMCP Managed Care & Specialty Pharmacy Annual Meeting this week in Denver Colorado. His topic, 340B Program Evolution: Understanding the Impact on Payers, will be co-presented with Krishna R. Patel, PharmD and Neil Minkoff, MD. AMCP brings together all the voices and visions of managed…

Read More

Marching Forward: CiiTA Hires a New Evaluator!

Please join us in welcoming the latest talented person to join the CiiTA team: Jennifer Soulagnet. Jennifer will be ably filling the role of Evaluator — enabling us to meet the growing needs of our clients. Prior to joining CiiTA, Jennifer worked as a senior communication strategist for both WebMD Health Services and Standard Insurance…

Read More

The End of the Road for HRSA’s 340B Mega Guidance?

A couple of weeks ago, we were in an uncertain landscape. On January 30, 2017, HRSA’s long-anticipated – and much debated — 340B “Mega Guidance” was withdrawn from the White House Office of Management and Budget (OMB). To move forward, the guidance would need to be resubmitted to OMB.

Read More

An Uncertain Landscape

Healthcare is an uncertain landscape at the moment. The incoming administration has promised a number of changes, including the potential repeal of the Affordable Care Act.  As a result, politicians, citizens, and companies don’t seem to have a handle on what is changing and what is staying the same. At CiiTA, we are also feeling…

Read More

CiiTA’s Changes

Among the perks of owning and growing a small business is that I get to celebrate the promotion of one of my colleagues, and also that I get to announce the hiring of two more.

Read More

A Win For Our Team

One of the prerogatives of being the leader of an extraordinary team of individuals is that you get to publicly recognize their success outside of the work hours as well.  Now is such an occasion. Gloria Harrison is a critical and valued member of the CiiTA team and is a close friend of us all.…

Read More

Introducing CiiTA LLC’s 340B Self-Reporting Assistance

Manufacturers are struggling with how best to respond to the increasing volume of 340B self-reporting offers and checks from Covered Entities.  In response, CiiTA is pleased to introduce the Manufacturer 340B Self-Reporting Assistance offering. CiiTA assists manufacturers by providing guidance and data analysis to support investigation into events triggering self-reporting letters and refund checks. Our…

Read More

CiiTA Managing Partner Jason Hardaway to Speak at 340B Manufacturer Summit

PORTLAND, Ore. – May 9, 2016 — CiiTA founder and managing partner Jason Hardaway is invited to speak at the upcoming 340B Manufacturer Summit in Washington, DC August 18-19, 2016. This event, hosted by CBI, breaks down and clarifies the impending regulations impacting 340B programs, provides strategies to develop comprehensive self-disclosure response and auditing processes, and best…

Read More

CiiTA Managing Partner Jason Hardaway to Speak at 15th Annual Medicaid and GP Congress

PORTLAND, Ore. – April 25, 2016 — CiiTA founder and managing partner Jason Hardaway is invited to speak at the upcoming 15th Annual Medicaid and GP Congress in Orlando, Florida May 18-20, 2016. This event, hosted by CBI, is an invaluable opportunity to learn and receive updates on government pharmaceutical programs while also having the opportunity…

Read More

Develop Your 340B Strategy

CiiTA has, through extensive experience, developed a set of best practices to help guide you through the creation of your 340B strategy. Download our process document to facilitate the development of your strategy.

Please enter your name.
Please enter a valid email address.
Something went wrong. Please check your entries and try again.